Your browser doesn't support javascript.
loading
A web-based psycho-educational intervention (Fex-Can) targeting sexual dysfunction and fertility-related distress in young adults with cancer: study protocol of a randomized controlled trial.
Lampic, C; Ljungman, L; Micaux Obol, C; Eriksson, L E; Wettergren, L.
Affiliation
  • Lampic C; Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
  • Ljungman L; Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
  • Micaux Obol C; Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
  • Eriksson LE; Department of Learning, Informatics, Management and Ethics, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
  • Wettergren L; School of Health Sciences, City, University of London, London, EC1V 0HB, UK.
BMC Cancer ; 19(1): 344, 2019 Apr 11.
Article in En | MEDLINE | ID: mdl-30975116
ABSTRACT

BACKGROUND:

This study protocol describes the clinical trial of the Fex-Can intervention, a web-based self-help program targeting sexual dysfunction and fertility-related distress. The psycho-educational intervention has been developed in collaboration with young patients with cancer and shown to be feasible. The primary objective is to determine whether the Fex-Can intervention, provided in addition to standard care, is superior to standard care in terms of reduction of sexual dysfunction and fertility-related distress directly after end of the 12-week program. The trial also aims to determine whether the intervention has an effect on the secondary outcomes including health-related quality of life, anxiety, depression, body image, fertility knowledge, and self-efficacy related to sexuality and fertility.

METHODS:

The trial has an randomized clinical trial (RCT) design with two parallel arms. The active groups receive either the version of the Fex-Can intervention targeting sexual problems or the version targeting fertility-related distress. Control groups receive standard care. Primary outcomes will be sexual function assessed with the Patient-Reported Outcomes Measurement Information System® Sexual Function and Satisfaction measure version 2.0 (SexFS) and fertility-related distress assessed with the Reproductive Concerns After Cancer scale (RCAC). The effect of the intervention will be evaluated directly after end of the program. Primary and secondary outcomes will also be assessed at the short- (12 weeks after end of program) and long-term (20 and 44 months after end of program) follow-up. At least 64 completers will be needed in each arm (total n = 256) to achieve adequate statistical power in the analyses. In order to increase the understanding of how the intervention brings about a possible change, semi-structured interviews will additionally be conducted with a purposeful sample shortly after completion of the intervention.

DISCUSSION:

If the Fex-Can intervention proves to be efficacious the necessary steps will be taken to implement it in routine care for young adults diagnosed with cancer. Healthcare could thereby be provided with an easily accessible, cost-effective intervention to offer to young adults suffering from fertility-related distress or sexual problems. TRIAL REGISTRATION ISRCTN36621459 . Registered 25 January 2016.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotherapy / Patient Education as Topic / Sexual Dysfunctions, Psychological / Fertility / Self-Management / Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Limits: Adult / Female / Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Sweden

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psychotherapy / Patient Education as Topic / Sexual Dysfunctions, Psychological / Fertility / Self-Management / Neoplasms Type of study: Clinical_trials / Guideline / Qualitative_research Limits: Adult / Female / Humans / Male Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Sweden